Editorial: Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches

Claudio de Lucia; Celestino Sardu; Laurent Metzinger; Coert J Zuurbier

doi:10.3389/fphys.2019.00253

Editorial: Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches

Front Physiol. 2019 Mar 19:10:253. doi: 10.3389/fphys.2019.00253. eCollection 2019.

Authors

Claudio de Lucia¹, Celestino Sardu², Laurent Metzinger³, Coert J Zuurbier⁴

Affiliations

¹ Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
² Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
³ EA4666 HEMATIM, CURS, University of Picardie Jules Verne, Amiens, France.
⁴ Laboratory of Experimental Intensive Care and Anesthesiology, Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam Infection & Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

No abstract available

Keywords: GLP-1-glucagon-like peptide-1; SGLT2 (sodium-glucose cotransporter 2) inhibitor; arrhythmia; diabetes; diastolic dysfunction; heart failure.

Publication types

Editorial